Clinical studies recruiting near Coronado

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · Southern California Research Center · Ipsen · NCT06016842 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Southern California GI & Liver Centers-Site Number: 8400062 · Sanofi · NCT07184931 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Southern California Research Center · Boehringer Ingelheim · NCT06632457 A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associa
Phase 2 · Southern California Research Center · Regeneron Pharmaceuticals · NCT05519475 Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Phase 3 · Southern California GI & Liver Centers - Coronado · Bausch Health Americas, Inc. · NCT07428538 A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Phase 2 · Southern California Research Center · Regeneron Pharmaceuticals · NCT07527910 Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
Phase 1 · Southern California Research Center · PharmaIN · NCT05490888 A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Acti
Phase 3 · Southern California GI & Liver Centers - Site Number: 840006 · Sanofi · NCT07185009 Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Southern California Research Centers · Gilead Sciences · NCT06029972 A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Pr
Phase 2 · Southern California Research Center · Mirum Pharmaceuticals, Inc. · NCT05050136 A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06215716 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Stryker Instruments · NCT03072927 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Phase 2 · Southern California Res. Ctr /ID# 265549 · AbbVie · NCT06548542 A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Y
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06613698 A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction-
Phase 2 · Southern California Research Center · Boehringer Ingelheim · NCT07325526 LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or A
Phase 3 · Southern California Research Center · Boehringer Ingelheim · NCT06632444 A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Col
Phase 3 · Southern California Research Center · Janssen Research & Development, LLC · NCT07196748 A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-
Phase 2 · Aligos Investigational Site · Aligos Therapeutics · NCT06963710 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Southern California GI & Liver Centers - Site Number: 840006 · Sanofi · NCT07184996 A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06318169 A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Southern California GI and Liver Centers (SCLC) · Eli Lilly and Company · NCT06598943 A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07519395 A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Phase 2/Phase 3 · Southern California Research Center · Janssen Research & Development, LLC · NCT07196722 A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholang
Phase N/A · Southern California Research Center · Ipsen · NCT06447168 Prospective Study to Assess a Diagnostic Aid for Cancer
Phase N/A · Southern California Research Center · Harbinger Health · NCT07046260 A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Di
Phase 3 · Southern California Research Center ( Site 5044) · Merck Sharp & Dohme LLC · NCT06430801

Look up another city

Look up another condition